IgE antibodies in cancer

Project: Research

Project Details

StatusFinished
Effective start/end date1/02/201823/12/2022

Funding

  • IGEM Therapeutics Ltd: £533,956.80
  • IGEM Therapeutics Ltd: £794,842.30
  • IGEM Therapeutics Ltd: £73,829.73